Tools for addressing SARS-CoV-2
Empowering researchers in the fight against COVID-19
Telesis Bio focuses on providing you, our customers and collaborators, with the tools and resources you need to change the world. Never has this been more important than right now.
Eight days from order to immunized mice
"I ordered gene fragments on the BioXp® reagent ordering portal, completed construction of five vaccine candidates against SARS-CoV-2, sequence-verified, manufactured RNA for animal testing, and immunized mice in just eight days."
Jesse Erasmus, PhD | University of Washington
Dedicated COVID-19 team
Whether you are interested in using our SARS-CoV-2 products for your research and development, or partnering with us to leverage our know-how and to develop novel solutions together, we are here, and we are ready. We have a dedicated COVID-19 team ready to answer your questions or discuss ways we can work together in the fight against COVID-19.
Our team is your team
To ensure that scientific advancements can continue despite stay-at-home orders and reduced laboratory staffing, we are also making our laboratory space and talent available to researchers who cannot return to their laboratories. We can store orders until you’re back in the lab, or ship them wherever you desire.
From synthetic DNA parts to full-length synthetic genomes
We are rapidly creating new SARS-CoV-2 tools and resources to support the scientific community’s efforts to develop diagnostics, therapeutics, and vaccines. From synthetic DNA parts to full-length synthetic genomes, to grants for front-line researchers, Telesis Bio is empowering researchers in the fight against COVID-19. All Telesis Bio SARS-CoV-2 research tools are available standalone, as a service, or on the BioXp® system — providing unprecedented speed and scale for building double-stranded DNA gene fragments, clones, and libraries.
All of us at Telesis Bio are fully committed to partnering with you and ensuring that the speed of science outpaces the spread of the coronavirus. Thank you for your efforts to make the world a better place, and for putting your trust in us.
Webinar
Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 full-length, synthetic genome — the causal agent of COVID-19
Application note
Take a deeper look into how the BioXp® system is enabling researchers around the world to rapidly synthesize SARS-CoV-2 genome parts and accelerate discovery pipelines
Research grant
Telesis Bio is donating funds towards the purchase of a BioXp® system for front-line researchers developing solutions to combat the spread of COVID-19